Korea Joongang Daily
Korea JoongAng Daily

GC LabCell gets approval for Phase 1 trials of CT303

GC LabCell won approval to start Phase 1 clinical trials of CT303, its treatment candidate for acute respiratory distress syndrome (ARDS).

2021-10-20

GC LabCell’s CT303 psoriasis treatment enters Phase 1 trials

GC LabCell’s CT303 psoriasis stem cell therapy candidate won approval for Phase 1 clinical trials in Korea, the pharmaceutical company said Thursday.

2021-08-19